Quarterly Report (10-q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(MARK ONE)

   X .QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2022

 

OR

 

        .TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________________ to __________________

 

Commission File No. 000-56293

 

Nine Alliance Science & Technology Group

(Exact name of registrant as specified in its charter)

 

Nevada	35-2515740
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

 

7325 Oswego Road

Liverpool, NY 13090

(Address of principal executive offices, zip code)

 

[phone]

(Registrant’s telephone number, including area code)

 

 (Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x.. No       .

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x. No  

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (check one):

Large accelerated filer	.	Accelerated filer	.
Non-accelerated filer	(Do not check if a smaller reporting company)	Smaller reporting company	x

As of March 31, 2022, there were 225,000,000 shares of common stock, $0.0001 par value per share, outstanding.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

 

As of May 10, 2022, the date of this filing, there were 225,000,000 shares of common stock, $0.0001 par value per share, outstanding.

1

 

 

 

 

 

 

NINE ALLIANCE SCIENCE & TECHNOLOGY GROUP

QUARTERLY REPORT ON FORM 10-Q

FOR THE PERIOD ENDED MARCH 31, 2022

 

INDEX

 

				Page
Part I.	Financial Information
	Item 1.		Financial Statements	4
			Balance Sheets as at March 31, 2022 (Unaudited) and September 30, 2021 (Audited).	4
			Statements of Operations for the Three months Ended March 31, 2022 and March 31, 2021 (Unaudited)	5
			Statements of Operations for the Six Months Ended March 31, 2022 and March 31, 2021 (Unaudited)
			Statements of Changes in Stockholders’ Equity for the Six Months Ended March 31, 2022 and March 31, 2021 (Unaudited).	6
			Statements of Cash Flow for the Six Months Ended March 31, 2022 and March 31, 2021 (Unaudited).	7
			Notes to the Financial Statements (Unaudited).	8
	Item 2.		Management’s Discussion and Analysis of Financial Condition and Results of Operations.	13
	Item 3.		Quantitative and Qualitative Disclosures About Market Risk.	18
	Item 4.		Controls and Procedures.	19
Part II.	Other Information
	Item 1.		Legal Proceedings.	20
	Item 1A.		Risk Factors	20
	Item 2.		Unregistered Sales of Equity Securities and Use of Proceeds.	20
	Item 3.		Defaults Upon Senior Securities.	20
	Item 4.		Mine Safety Disclosures	20
	Item 5.		Other Information.	20
	Item 6.		Exhibits.	21
Signatures				22

 

 

2

 

 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q of Nine Alliance Science & Technology Group, a Nevada corporation (the “Company”), contains “forward-looking statements.”  In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “could”, “expects”, “plans”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or the negative of such terms and other comparable terminology.  These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, competition, expected activities and expenditures as we pursue our business plan, and the adequacy of our available cash resources.  Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.  Actual results may differ materially from the predictions discussed in these forward-looking statements.  The economic environment within which we operate could materially affect our actual results. Additional factors that could materially affect these forward-looking statements and/or predictions include, among other things: the Company’s need for and ability to obtain additional financing and the demand for the Company’s products, and other factors over which we have little or no control; and other factors discussed in the Company’s filings with the Securities and Exchange Commission (“SEC”).

 

We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.  We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as required by law.

 

Our financial statements are stated in United States dollars ($US) and are prepared in accordance with United States Generally Accepted Accounting Principles.

 

In this quarterly report, unless otherwise specified, all references to "common stock" refer to the common shares in our capital stock.

 

As used in this annual report, the terms "we", "us", "our", “Nine Alliance" mean Nine Alliance Science & Technology Group, unless the context clearly requires otherwise.

3

 

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1:   FINANCIAL STATEMENTS. 

 

Nine Alliance Science & Technology Group
BALANCE SHEETS

 

 

		(Unaudited)				(Audited)
		March 31,				September 30,
		2022				2021
ASSETS
Current Assets:
Cash		$	—			$	—
Total Current Assets			—				—
TOTAL ASSETS		$	—			$	—
LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities:
Accounts Payable		$	7,628			$	6,847
Accounts Payable - Related Party			5,035				25,143
Income Tax Payable			2,303				2,303
Total Current Liabilities			14,966				34,293
Total Liabilities		$	14,966			$	34,293
COMMITMENTS AND CONTINGENCIES
Stockholder's Equity
Preferred Stock; Blank Check, par value $0.0001,
10,000,000 shares Authorized,  0 shares Issued and Outstanding
as of March 31, 2022 and  September 30, 2021			—				—
Common Stock, par value $0.0001,
290,000,000 shares Authorized,  225,000,000 shares Issued and Outstanding
as of March 31, 2022 and 75,000,000 as of September 31, 2021			22,500				7,500
Additional Paid-In Capital			52,194				38,500
Accumulated Deficit			(89,660	)			(80,293	)
Total Stockholder's Deficit			(14,966	)			(34,293	)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)		$	—			$	—
The accompanying notes are an integral part of these unaudited financial statements

 

4 

 

 

 

 

Nine Alliance Science & Technology Group

STATEMENTS OF OPERATIONS

(Unaudited)

 

		For the Three Months Ended								For the Six Months Ended
		March 31,								March 31,
		2022				2021				2022				2021
Revenues:		$	—			$	—			$	—			$	—
Operating Expenses
General and Administrative Expenses			998				625				3,294				970
Professional Fees			3,924				4,157				6,073				7,169
Total Operating Expenses			4,922				4,782				9,367				8,139
Loss From Operations			(4,922	)			(4,782	)			(9,367	)			(8,139	)
Income Tax Provision		$	—			$	—			$	—			$	—
Net Loss		$	(4,922	)		$	(4,782	)		$	(9,367	)		$	(8,139	)
Basic & Diluted Loss per Common Share		$	(0.00	)		$	(0.00	)		$	(0.00	)		$	(0.00	)
Weighted Average Common Shares
Outstanding			225,000,000				75,000,000				225,000,000				75,000,000
The accompanying notes are an integral part of these unaudited financial statements

5  

 

 

 

Nine Alliance Science & Technology Group

STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)

For the Three Months Ended March 31, 2021

(Unaudited)

 

			Common Stock
			Shares				Par Value				Additional Paid-In Capital				Accumulated Deficit				Total Stockholders' Equity (Deficit)
Balance as of September 30, 2020 (Restated)			5,000,000			$	500			$	43,500			$	(62,985	)		$	(18,985	)
Issuance of Common Stock for Debt			70,000,000			$	7,000			$	(5,000	)		$	—			$	2,000
Net Loss for the Three Months Ended December 31, 2020			—			$	—			$	—			$	(3,357	)		$	(3,357	)
Balance as of December 31, 2020			75,000,000			$	7,500			$	38,500			$	(66,342	)		$	(20,342	)
Net Loss for the Three Months Ended March 31, 2021			—			$	—			$	—			$	(4,782	)		$	(4,782	)
Balance as of March 31, 2021			75,000,000			$	7,500			$	38,500			$	(71,124	)		$	(25,124	)
The accompanying notes are an integral part of these unaudited financial statements

 

Nine Alliance Science & Technology Group

STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)

For the Three Months Ended March 31, 2022

(Unaudited)

 

			Common Stock
			Shares				Par Value				Additional Paid-In Capital				Accumulated Deficit				Total Stockholders' Equity (Deficit)
Balance as of September 30, 2021			75,000,000			$	7,500			$	38,500			$	(80,293	)		$	(34,293	)
Issuance of Common Stock for Debt			150,000,000			$	15,000			$	13,694			$	—			$	28,694
Net Loss for the Three Months Ended December 31, 2021			—											$	(4,445	)		$	(4,445	)
Balance as of December 31, 2021			225,000,000			$	22,500			$	52,194			$	(84,738	)		$	(10,044	)
Net Loss for the Three Months Ended March 31, 2022			—				—				—			$	(4,922	)		$	(4,922	)
Balance as of March 31, 2022			225,000,000			$	22,500			$	52,194			$	(89,660	)		$	(14,966	)
The accompanying notes are an integral part of these unaudited financial statements

6 

 

 

 

Nine Alliance Science & Technology Group

STATEMENT OF CASH FLOWS

(Unaudited)

 

		For the Six Months Ended
		March 31,
		2022				2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss		$	(9,367	)		$	(8,139	)
Adjustments to reconcile net loss to net cash used in operating activities:
Changes In:
Accounts Payable			781				2,319
Accounts Payable - Related Party			(20,108	)			3,820
Net Cash Used in Operating Activities		$	(28,694	)		$	(2,000	)
CASH FLOWS FROM FINANCING
Issuance of Shares for Capital			28,694				2,000
Net Cash Provided by Financing Activities		$	28,694			$	2,000
Net Increase (Decrease) in Cash		$	—
Cash at the Beginning of Year		$	—			$	—
Cash at the End of Year		$	—			$	—
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the year for:
Interest		$	—			$	—
Taxes		$	—			$	—

 

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Issuance of 70,000,000 shares for Common Stock in exchange for $2,000 in Debt paid by a Related Party.
Issuance of 150,000,000 shares for Common Stock in exchange for $28,694 in Debt paid by a Related Party.
The accompanying notes are an integral part of these unaudited financial statements

 

 

7 

 

 

 

 

 

NINE ALLIANCE SCIENCE & TECHNOLOGY GROUP

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED MARCH 31, 2022 (UNAUDITED)

 

NOTE 1 – NATURE OF OPERATIONS

 

Nine Alliance Science and Technology Group (the “Company”) was incorporated as Paramount Supply Inc. and established under the Corporation Laws of the State of Nevada on September 12, 2014. On September 29, 2017, the Company filed a Certificate of Amendment changing the name from “Paramount Supply Inc.” to “Nine Alliance Science and Technology Group”. The Company was formed for the purpose of marketing and distributing ladies fashion handbags. At the end of 2017 the Company became dormant and ceased all business operations.

 

On August 27, 2020, a motion and application was made to appoint a Custodian of the Company based on prior management abandoning its responsibilities to continue making filings at the Nevada Secretary of State’s office and for failing to hold a stockholders’ meeting in over 3 years and otherwise failing to keep current in its obligations to the Company.  Upon motion and application to the District Court, Clark County Nevada, the Court granted the request for Custodian for the Company (“Custodian”).   Upon granting the motion, the Court issued an Order acknowledging that the Custodian has performed all of the duties that had been required of it and the management of the Company will revert exclusively to the officers and directors appointed by the Custodian. In the Revival of the Company, Investment Reserves Series, as the Custodian of the Company, appointed Joseph Passalaqua as CEO, CFO and Secretary. As of the date of this report, March 31, 2022, Joseph Passalaqua is CEO, CFO and Secretary.

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES 

 

2.1 Basis of Presentation

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. The Company has adopted a September 30 fiscal year end.

 

2.2 Use of Estimates and Assumptions

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Due to the limited level of operations, the Company has not had to make material assumptions or estimates other than the assumption that the Company is a going concern.

 

2.3 Cash and Cash Equivalents

The Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes.

 

2.4 Fair Value of Financial Instruments

The Company’s financial instruments consist of accounts payable and loans to shareholders. The carrying amount of financial instruments approximates fair value because of the short-term nature of these items.

 

2.5 Stock-Based Compensation

For the six months ended March 31, 2022 and the year ended September 30, 2021, the Company has not issued any stock-based payments to its employees Stock-based compensation is accounted for at fair value in accordance with ASC 718, when applicable. To date, the Company has not adopted a stock option plan and has not granted any stock options. 

 

 

 

8

 

 

 

 

 

 

NINE ALLIANCE SCIENCE & TECHNOLOGY GROUP

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED MARCH 31, 2022 (UNAUDITED)

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

.

2.6 Income Taxes

The Company follows the asset and liability method of accounting for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the estimated tax consequences attributable to differences between the financial statement carrying values and their respective income tax basis (temporary differences). The effect on deferred income tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Future tax benefits which arise as result of accumulated losses have not be recognized in these financial statements, as their realization is not likely to occur.

 

2.7 Basic Income (Loss) Per Share

The Company computes loss per share in accordance with “ASC-260”, “Earnings per Share” which requires presentation of both basic and diluted earnings per share on the face of the statement of operations.

 Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted loss per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive.

 For the six months ended March 31, 2022 and the year ended September 30, 2021 there were no potentially dilutive debt or equity instruments issued or outstanding and any such shares would have been excluded from the computation because they would have been anti-dilutive as the Company incurred losses in this period.

 

2.8 Commitments and Contingencies

The Company follows ASC 440 & ASC 450, subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies and commitments respectively. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur.

The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

 2.9 Recent Accounting Pronouncements

The Company reviewed all the recently issued, but not yet effective, accounting pronouncements and we do not believe any of these pronouncements will have a material impact on the Company.

  

 

 

9

 

 

 

 

.NINE ALLIANCE SCIENCE & TECHNOLOGY GROUP

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED MARCH 31, 2022 (UNAUDITED)

 

 

  NOTE 3 – GOING CONCERN

 

The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred a loss since Inception (March 25, 2008) resulting in an accumulated deficit of $89,660 as of March 31, 2022 and further losses are anticipated in the development of its business. Further, the Company has current liabilities in excess of current assets and has a stockholders’ deficit at March 31, 2022. These factors raise substantial doubts about the Company’s ability to continue as a going concern for a period of one year from the issuance of these financial statements.

 

Further, the effects of Covid-19 could also impact our ability to operate under the going concern and maintain sufficient liquidity to continue operations. The impact of COVID-19 on companies is evolving rapidly and its future effects are uncertain. There are material uncertainties from Covid-19 that cast significant doubt on the company’s ability to operate under the going concern. It is possible that our company will have issues relating to the current situation that will need to be considered by management in the future. There will be a wide range of factors to take into account in going concern judgments and financial projections including travel bans, restrictions, government assistance and potential sources of replacement financing, financial health of suppliers and customers and their effect on expected profitability and other key financial performance ratios including information that shows whether there will be sufficient liquidity to continue to meet obligations when they are due.

 

The Company filed a Registration Statement; Form-10-12g on June 16, 2021 and was effective 60 days post filing and the September 30, 2021 10K Annual filing in compliance with SEC regulations for effective companies. Management believes that this plan provides an opportunity for the Company to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with loans from directors and/or private placement of common stock. The failure to achieve the necessary levels of profitability or obtaining additional funding would be detrimental to the Company.

 

NOTE 4 – COMMON STOCK

 

On September 23, 2014, the Company issued 4,000,000 shares of common stock for a purchase price of $0.001 per share to its sole Director. The Company received aggregate gross proceeds of $4,000.

 

On September 2, 2015, the Company issued 1,000,000 shares of common stock for a purchase price of $0.04 to 30 independent investors pursuant to an offering on Registration Statement on Form S-1. The Company received proceeds of $40,000.

 

On October 31, 2020, the Company issued 70,000,000 shares of Common Stock to Friction & Heat LLC; Joseph Passalaqua as Managing Member, in exchange for debt in the amount of $2,000 paid to the Company’s Transfer Agent.

 

On February 25, 2021, the Company filed a Certificate of Amendment through which the par value has been changed from $0.001 to $0.0001. This change in par value has been applied retroactively in the financial statements presented for the year ended September 30, 2020 and September 30, 2019. The Company changed the par value to increase the possibility of attracting a merger candidate.

 

Through this amendment (effective February 25, 2021) Company also increased the authorized shares from 75,000,000 to 300,000,000, of which 290,000,000 will be Common Stock with a par value of $0.0001 and 10,000,000 will be Blank Check Preferred Stock with a par value of $0.0001. Before this amendment, Company did not have any authorized Preferred Stock. 

 

10

 

 

 

 

 

NINE ALLIANCE SCIENCE & TECHNOLOGY GROUP

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED MARCH 31, 2022 (UNAUDITED)

 

NOTE 4 – COMMON STOCK (Continued)

 

On December 7, 2021, the Company issued 150,000,000 shares of Common Stock to Friction & Heat LLC; Joseph Passalaqua as Managing Member, in exchange for debt in the amount of $28,694, paid for Company expenses in 2020 and 2021.

 

As of the year ended September 30, 2021, the Company had 290,000,000 shares of Common Stock Authorized and 75,000,000 shares of Common Stock Issued and Outstanding and 10,000,000 shares of Blank Check Preferred Stock Authorized and 0 Issued and Outstanding.

 

As of the six months ended March 31, 2022, the Company had 290,000,000 shares of Common Stock Authorized and 225,000,000 shares of Common Stock Issued and Outstanding and 10,000,000 shares of Blank Check Preferred Stock Authorized and 0 Issued and Outstanding.

 

NOTE 5 – RELATED PARTY TRANSACTIONS

 

In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by shareholders or directors. Amounts represent advances or amounts paid in satisfaction of liabilities. The advances were considered temporary in nature.

 

On October 14, 2020, Joseph Passalaqua, an officer and Related Party of the Company advanced the Company $2,000 to cover the Company’s Transfer Agent fees. The amount was non-interest bearing, payable on demand and unsecured. On October 31, 2020, the Company issued 70,000,000 shares of Common Stock to Friction & Heat LLC; Joseph Passalaqua as Managing Member, in exchange for debt in the amount of $2,000 paid to the Company’s Transfer Agent.. As of March 31, 2022, this amount is paid in full.

 

From July 2020 – November 2021, Joseph Passalaqua, an officer and Related Party, advanced the Company $23,444 to cover the Company’s expenses, that included Auditor fees, Legal fees, Stock Transfer Agent, State of Nevada corporation fees. This amount was included in a Convertible Note dated November 30, 2021 and was non-interest bearing, payable on demand and unsecured. On December 7, 2021, the Company issued 150,000,000 shares of Common Stock to Friction & Heat LLC; Joseph Passalaqua as Managing Member, in exchange for $28,694 debt conversion, which included this amount.As of March 31, 2022, this is paid in full.

 

During the years ended September 2019 – September 2021, Lyboldt-Daly, Inc; its sole officer is Joseph Passalaqua, who is also an officer and Related Party of Nine Alliance Science and Technology Group, Inc., provided the internal accounting for the Company. The amount of $5,250 was included in a Convertible Note owed to Joseph Passalaqua, dated November 30, 2021 and was non-interest bearing, payable on demand and unsecured. On December 7, 2021, the Company issued 150,000,000 shares of Common Stock to Friction & Heat LLC; Joseph Passalaqua as Managing Member, in exchange for $28,694 in debt conversion, which included this amount. As of March 31, 2022, this is paid in full.

 

In the six months ended March 31, 2022, Joseph Passalaqua, an officer and Related Party, advanced the Company $3,035 to cover the Company’s expenses that included Stock Transfer Agent and EDGAR/XBRL Agent fees. This amount is non-interest bearing, payable on demand and unsecured. As of March 31, 2022, $3,035 is outstanding and included in Related Party Payable.

 

In the six months ended March 31, 2022, Lyboldt-Daly, Inc; its sole officer is Joseph Passalaqua, who is also an officer and Related Party of Nine Alliance Science and Technology Group, Inc., provided the internal accounting for the Company in the amount of $2,000. This amount is non-interest bearing, payable on demand and unsecured. As of March 31, 2022, $2,000 is outstanding and included in Related Party Payable.

 

The Company currently operates out of an office of a Related Party- the sole Officer, Joseph Passalaqua, free of rent.

 

 

11

 

 

 

 

 

NINE ALLIANCE SCIENCE & TECHNOLOGY GROUP

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS

FOR SIX MONTHS ENDED MARCH 31, 2022 (UNAUDITED)

 

NOTE 6 – INCOME TAXES

 

As of six months ended March 31, 2022, the Company had net operating loss carry forwards of approximately $89,660 that may be available to reduce future years' taxable income in varying amounts through 2042.

 

As of the year ended September 30, 2021, the Company had net operating loss carry forwards of approximately $80,293 that may be available to reduce future years' taxable income in varying amounts through 2041.

 

Future tax benefits which arise as a result of these losses have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards.

 

The 21% tax rate provision for Federal income tax consists of the following:

		March 31,       2022				September 30,        2021
Federal income tax benefit attributable to:
Current operations		$	18,829			$	16,862
Less: change in valuation allowance			(18,829	)			(16,862	)
Net provision for Federal income taxes		$	—			$	—

 

The cumulative tax effect at the expected rate of 35% of significant items comprising our net deferred tax amount is as follows:

 

		March 31, 2022				September 30, 2021
Deferred tax asset attributable to:
Net operating loss carry over		$	31,381			$	28,103
Less: valuation allowance			(31,381	)			(28,103	)
Net deferred tax asset		$	—			$	—

  

 

Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards of approximately $84,738 for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur net operating loss carry forwards may be limited as to use in future years. The Company’s returns are open to examination by the Internal Revenue Services for all tax years since inception.

 

NOTE 7 - SUBSEQUENT EVENTS

 

The Company evaluated all other events or transactions that occurred after March 31, 2022 through May 10, 2022. The Company determined that it does not have any other subsequent event requiring recording or disclosure in the financial statements for the year ended September 30, 2021.  

 

 

 

12

 

 

 

 

 

 

ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

The following discussion and analysis should be read in conjunction with, and is qualified in its entirety by, our financial statements (and notes related thereto) and other more detailed financial information appearing elsewhere in this Quarterly Report on Form 10-Q. Consequently, you should read the following discussion and analysis of our financial condition and results of operations together with such financial statements and other financial data included elsewhere in this Quarterly Report on Form 10-Q. Some of the information contained in this discussion and analysis are set forth elsewhere in this prospectus, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. You should review the “Risk Factors” section of our Annual Report on Form 10-K for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.

 

Statements in this section and elsewhere in this Form 10-Q that are not statements of historical or current fact constitute “forward-looking” statements.

 

OVERVIEW OF OUR PERFORMANCE AND OPERATIONS

 

Our Business and Recent Developments

 

Nine Alliance Science & Technology Group (“Nine Alliance”, “We”, or the “Company”) was incorporated in the State of Nevada on September 12, 2014, under the name Paramount Supply Inc. The Company then known as Paramount Supply Inc. last filed a financial report with the SEC on August 25, 2017. On September 29, 2017, our name was changed to Nine Alliance Science & Technology Group. On August 27, 2020, a motion and application was made to appoint a Custodian of the Company based on prior management abandoning its responsibilities to continue making filings at the Nevada Secretary of State’s office and for failing to hold a shareholders’ meeting in over 3 years and otherwise failing to keep current in its obligations to the Company.  Upon motion and application to the District Court, Clark County Nevada, the Court granted the request for Custodian for the Company (“Custodian”).   Upon granting the motion, the Court issued an Order acknowledging that the Custodian has performed all of the duties that had been required of it and the management of the Company will revert exclusively to the officers and directors appointed by the Custodian. In the Revival of the Company, Investment Reserves Series, as the Custodian of the Company, appointed Joseph Passalaqua as CEO, CFO and Secretary.

 

The Company is a “blank check company,” as that term is defined in Rule 419(a)(2) of Regulation C of the Securities Act of 1933, as amended. We have not had preliminary contact or discussions with, nor do we have any present plans, proposals, arrangements, or understandings with, any representatives of the owners of any business or company regarding the possibility of an acquisition or merger. We are a “shell company” within the meaning of Rule 405, promulgated pursuant to Securities Act, because we do have no hard assets and real business operations. 

 

From inception until the date of this filing we have had limited operating activities, primarily consisting of the incorporation of our company and the initial equity funding by our sole officer and director. We received our initial funding of $4,000 from a previous sole officer and director at that time who purchased 4,000,000 shares of common stock at $0.001 per share.  Our independent auditor has issued an audit opinion for our Company which includes a statement expressing substantial doubt as to our ability to continue as a going concern. 

 

Previous business operations of the Company generated limited revenues and the Company currently has no business operations.

No revenue has been generated in the last two years ended September 30, 2020 and September 30, 2021. 

 

On June 2, 2021, we voluntarily filed a termination of our registration statement on Form 15-15D pursuant to Rule 15d-6 and our termination becomes effective 90 days thereafter.  The Company has since been seeking a merger target and has been evaluating various opportunities.

 

We never sold any securities under the offering statement, so there was no need to keep the prospectus and Form S-1 filing current.

 

13

 

 

 

 

 

The Company filed a Registration Statement; Form-10-12g on June 16, 2021 and was effective 60 days post filing.

 

We are subject to the requirements of Regulation 13A under the Exchange Act, which require us to file annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, and we are required to comply with all other obligations of the Exchange Act applicable to issuers filing registration statements pursuant to Section 12(g) of the Exchange Act.

 

We are not currently engaged in any business operations. We are, however, in the process of attempting to identify, locate, and if warranted, acquire new commercial opportunities. The Company is currently attempting to locate and negotiate with eligible portfolio companies to acquire an interest in them. In addition to acquiring an interest in them, the Company intends to assist these portfolio companies with raising capital and offer them substantial managerial assistance needed to succeed.

 

The authorized capital stock of Nine Alliance Science & Technology Group consists of 290,000,000 shares of Common Stock, $0.0001 par value per share (the “Common Stock”) and 10,000,000 shares of Preferred Stock, $0.0001 par value per share (the “Preferred”).

 

As of our previous year ended September 30, 2021, there were 75,000,000 shares of Common Stock issued and outstanding and no shares of Preferred Stock issued and outstanding. As of the six months ended March 31, 2022, there were 225,000,000 shares of Common Stock issued and outstanding and no shares of Preferred Stock issued and outstanding.

 

Our Business 

 

The Company is currently attempting to locate and negotiate with eligible portfolio companies to acquire an interest in them. In addition to acquiring an interest in them, the Company intends to assist these portfolio companies with raising capital and offer them substantial managerial assistance needed to succeed.

 

We are currently considered a shell company Rule 405 defines a shell company as a company with 1) no or nominal operations, and either 2)no or nominal assets, 3) assets consisting solely of cash and cash equivalents, or 4) assets consisting of any amount of cash and cash equivalents and nominal other assets. We will remain classified as a shell company until we qualify for an exemption pursuant to Rule 144 (i)(2) by meeting the following requirements: Nine Alliance Science & Technology Group is no longer a shell company and has not been one for a year, it mandatorily files reports with the SEC, it has filed all required reports during the past 12 months, and it has been over a year since the current Form 10 information was filed. Security holders will not be able to rely on Rule 144 for the resale of restricted and/or control securities as long as JMKJ remains classified as a shell corporation. 

 

Our current business address is: 7325 Oswego Road, Liverpool, NY 13090 .

Our telephone number is [phone].

 

This location serves as our primary office for planning and implementing our business plan. Management believes the current premises arrangements are sufficient for its needs for at least the next 12 months.

 

Employees

 

We have no employees. 

 

 

 

14

 

 

 

 

 

Results of Operations for the Three Months Ended March 31, 2022 and March 31, 2021

 

Revenues

 

We have generated revenues of $0 and $0 for the three months ended March 31, 2022 and March 31, 2021.

 

Operating and Administrative Expenses

 

Operating expenses for the three months ended March 31, 2022 were $4,922 compared with $4,782 for the three months ended March 31, 2021.  The increase in operating expenses were attributable to a increase in general and administrative expenses of $373, from $625 for the three months March 31, 2021 to $998 for the three months ended March 31, 2022 and included a decrease of professional fees of $233, from $4,782 for the three months ended March 31, 2021 to $3,924 for the three months ended March 31, 2022.

 

Loss from Operations

 

Operating Loss before income tax for the three months ended March 31, 2022 was $(4,922), an increase of $140 for the comparable period of March 31, 2021, of which the loss from operations was $(4,782). This increase was primarily attributable to General and Administrative fees, that included EDGAR/XBRL formatting for filings and Stock Transfer fees.

 

Net loss

 

The Net loss for the three months ended March 31, 2022 was $(4,922), compared to a Net loss of $(4,782) for the three months ended March 31, 2021. This increase was primarily attributable to general and administrative fees, that included EDGAR/XBRL formatting for filings and Stock Transfer fees.  The net loss in 2021 was primarily attributable to an increase in general and administrative fees from operations.

 

Results of Operations for the Six Months Ended March 31, 2022 and March 31, 2021

 

Revenues

 

We have generated revenues of $0 and $0 for the six months ended March 31, 2022 and March 31, 2021.

 

Operating and Administrative Expenses

 

Operating expenses for the six months ended March 31, 2022 were $9,367 compared with $8,139 for the six months ended March 31, 2021.  The increase in operating expenses were attributable to an increase in general and administrative expenses of $2,324, from $970 for the six months March 31, 2021 to $3,294 for the six months ended March 31, 2022 and included a decrease of professional fees of $1,096, from $7,169 for the six months ended March 31, 2021 to $6,073 for the six months ended March 31, 2022.

 

Loss from Operations

 

Operating Loss before income tax for the six months ended March 31, 2022 was $(9,367), an increase of $1,228 for the comparable period of March 31, 2021, of which the loss from operations was $(9,139). This increase was primarily attributable to General and Administrative fees, that included EDGAR/XBRL formatting for filings and Stock Transfer fees.

 

Net loss

 

The Net loss for the six months ended March 31, 2022 was $(9,367), compared to a Net loss of $(8,139) for the six months ended March 31, 2021. This increase was primarily attributable to general and administrative fees, that included EDGAR/XBRL formatting for filings and Stock Transfer fees.  The net loss in 2021 was primarily attributable to an increase in general and administrative fees from operations.

 

 

 

 

15

 

 

 

 

 Liquidity and Capital Resources

 

As of the year ended September 30, 2021 and the six months ended March 31, 2022, the Company's total assets were $0.

 

As of the last year ended, September 30, 2021, the Company had total liabilities of $34,293 that consisted of $6,857 in Accounts Payable, $25,143 in Accounts Payable owed to Related Parties; Joseph Passalaqua and Lyboldt-Daly Inc., of which Joseph Passalaqua is the sole officer and $2,303 in Income Tax Payable. These amounts are non-interest bearing, payable upon demand and unsecured.

 

As of the six months ended March 31, 2022, the Company had total liabilities of $14,966 that consisted of $7,628 in Accounts Payable, $5,035 in Accounts Payable owed to Related Parties; Joseph Passalaqua and Lyboldt-Daly Inc., of which Joseph Passalaqua is the sole officer and $2,303 in Income Tax Payable. The decrease in amounts in Accounts Payable owed to Related Parties in the six months ended March 31, 2022, was due to an conversion of debt in the amount of 28,694, in exchange for an issuance of 150,000,000 shares of common stock on December 7, 2021. These amounts are non-interest bearing, payable upon demand and unsecured.

 

As of the last year ended September 30, 2021, the Company has a working capital deficit of $34,293,

 As of the six months ended March 31, 2022, the Company has a working capital deficit of $14,966.

 

Working Capital and Cash Flows

 

Working Capital		March 31,				September 31,
		2022				2021
Current Assets		$	—			$	—
Current Liabilities			14,966				34,,293
Working Capital (Deficit)		$	(14,966	)		$	34,293

 

Cash Flows		March 31,				March 31,
		2022				2021
Cash Flows from (used in) Operating Activities		$	28,694			$	2,000
Cash Flows from (used in) Financing Activities			(28,694	)			(2,000	)
Net Increase (decrease) in Cash During Period		$	—			$	—

  

Cash Flows from Operating Activities

 

During the six months ended March 31, 2022 and March 31, 2021, the Company had $28,694 and $2,000, respectively, in cash used for operating activities.

 

Cash Flows from Financing Activities

 

During the six months March 31, 2022 and March 31, 2021, the Company had $28,694 and $2,000, respectively, in cash received from financing activities.

 

Critical Accounting Policies

 

 Going Concern

 

We have not attained profitable operations and are dependent upon the continued financial support from our shareholders, the ability to raise equity or debt financing, and the attainment of profitable operations from our future business. These factors raise substantial doubt regarding our ability to continue as a going concern. 

 

Our ability to continue as a going concern is dependent upon our ability to generate future profitable operations and/or to obtain the necessary financing to meet our obligations and repay our liabilities arising from normal business operations when they come due. Our ability to continue as a going concern is also dependent on our ability to find a suitable target company and enter into a possible reverse merger with such company. Management’s plan includes obtaining additional funds by equity financing through a reverse merger transaction and/or related party advances; however, there is no assurance of additional funding being available.

 The Company, as of the date of this filing had approximately $0 in cash and has not earned any revenues from operations to date. For the last six months ending March 31, 2022, our operating expenses were $9,367. In the previous two fiscal years our operating expenses were $17,308 and $8,737 in the years ended September 30, 2021 and September 30, 2020 respectively, consisting primarily of professional fees, administrative expenses and filing fees. The ongoing expenses of the Company will be related to seeking out a suitable acquisition as well as mandatory filing requirements including our reporting requirements under the Securities Exchange Act of 1934 upon effectiveness of this registration statement.  

16

 

 

 The Company continues to rely on borrowings and financings either arranged by the Company’s President or through entities controlled by the President. In the next 12 months we expect to incur expenses equal to approximately $20,000 related to legal, accounting, audit, and other professional service fees incurred in relation to the Company’s Exchange Act filing requirements. The costs related to the acquisition of a business combination target company vary widely and are dependent on a variety of factors including, but not limited to, the amount of time it takes to complete a business combination, the location of the target company, the size and complexity of the business of the target company, whether stockholders of the Company prior to the transaction will retain equity in the Company, the scope of the due diligence investigation required, the involvement of the Company’s auditors in the transaction, possible changes in the Company’s capital structure in connection with the transaction, and whether funds may be raised contemporaneously with the transaction. Therefore, we believe such costs are unascertainable until the Company identifies a business combination target. These conditions raise substantial doubt about our ability to continue as a going concern. The Company is currently devoting its efforts to locating merger candidates. The Company’s ability to continue as a going concern is dependent upon our ability to develop additional sources of capital, locate and complete a merger with another company, and ultimately, achieve profitable operations.

 

The Company may consider a business which has recently commenced operations, is a developing company in need of additional funds for expansion into new products or markets, is seeking to develop a new product or service, or is an established business which may be experiencing financial or operating difficulties and is in need of additional capital. Our management believes that the public company status that results from a combination with the Company will provide such company greater access to the capital markets, increase its visibility in the investment community, and offer the opportunity to utilize its stock to make acquisitions. There is no assurance that we will in fact have access to additional capital or financing as a public company. In the alternative, a business combination may involve the acquisition of, or merger with, a company which does not need substantial additional capital, but which desires to establish a public trading market for its shares, while avoiding, among other things, the time delays, significant expense, and loss of voting control which may occur in a public offering.

 

Our sole officer and director has not had any preliminary contact or discussions with any representative of any other entity regarding a business combination with us. Any target business that is selected may be a financially unstable company or an entity in its early stages of development or growth, including entities without established records of sales or earnings. In that event, we will be subject to numerous risks inherent in the business and operations of financially unstable and early stage or potential emerging growth companies. In addition, we may effect a business combination with an entity in an industry characterized by a high level of risk, and, although our management will endeavor to evaluate the risks inherent in a particular target business, there can be no assurance that we will properly ascertain or assess all significant risks.

Our management anticipates that it will likely be able to effect only one business combination, due primarily to our limited financing and the dilution of interest for present and prospective stockholders, which is likely to occur as a result of our management’s plan to offer a controlling interest to a target business in order to achieve a tax-free reorganization. This lack of diversification should be considered a substantial risk in investing in us, because it will not permit us to offset potential losses from one venture against gains from another.

 

The Company anticipates that the selection of a business combination will be complex and extremely risky. While the Company is in a competitive market with a small number of business opportunities, through information obtained from industry professionals including attorneys, investment bankers, and other consultants with experience in the reverse merger industry, our management believes that there are opportunities for a business combination with firms seeking the perceived benefits of becoming a publicly traded corporation. Such perceived benefits of becoming a publicly traded corporation include, among other things, facilitating or improving the terms on which additional equity financing may be obtained, providing liquidity for the principals of and investors in a business, creating a means for providing incentive stock options or similar benefits to key employees, and offering greater flexibility in structuring acquisitions, joint ventures and the like through the issuance of stock. Potentially available business combinations may occur in many different industries and at various stages of development, all of which will make the task of comparative investigation and analysis of such business opportunities extremely difficult and complex.

 

We do not currently intend to retain any entity to act as a “finder” to identify and analyze the merits of potential target businesses. 

 

17

 

 

 

 

 

 

 We have not established a specific timeline nor have we created a specific plan to identify an acquisition target and consummate a business combination. We expect that our management and the Company, through its various contacts and affiliations with other entities will locate a business combination target. We expect that funds in the amount of approximately $20,000 will be required in order for the Company to satisfy its Exchange Act reporting requirements during the next 12 months, in addition to any other funds that will be required in order to complete a business combination. Such funds can only be estimated upon identifying a business combination target. Our management and stockholders have indicated an intent to advance funds on behalf of the Company as needed in order to accomplish its business plan and comply with its Exchange Act reporting requirements, however, there are no agreements in effect between the Company and our management or stockholders specifically requiring they provide any funds to the Company. Therefore, there are no assurances that the Company will be able to obtain the required financing as needed in order to consummate a business combination transaction.

 

The effects of Covid -19 could impact our ability to operate under the going concern and maintain sufficient liquidity to continue operations. The impact of COVID-19 on companies is evolving rapidly and its future effects are uncertain. There are material uncertainties from Covid-19 that cast significant doubt on the company’s ability to operate under the going concern. It is possible that our company will have issues relating to the current situation that will need to be considered by management in the future. There will be a wide range of factors to take into account in going concern judgments and financial projections including travel bans, restrictions, government assistance and potential sources of replacement financing, financial health of suppliers and customers and their effect on expected profitability and other key financial performance ratios including information that shows whether there will be sufficient liquidity to continue to meet obligations when they are due.

 

The Company filed a Registration Statement; Form-10 and was effective 60 days post filing and a Form 10K for the year ended September 30, 2021 and a Form 10Q ended December 31, 2021 and will continue to file all required annual and quarterly reports on schedule. Management believes that this plan provides an opportunity for the Company to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with existing cash on hand and loans from directors and/or private placement of common stock. The failure to achieve the necessary levels of profitability or obtaining additional funding would be detrimental to the Company. 

 

Off-Balance Sheet Arrangements

 

We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.

 

Default on Notes

 

There are currently no notes in default.

 

Other Contractual Obligations

 

As of the year ended September 30, 2021 and the six months ended March 31, 2022, we did not have any contractual obligations.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

As a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act), we are not required to provide the information called for by this Item 3.

 

 

 

18

 

 

 

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures.

 

We carried out an evaluation, under the supervision and with the participation of our management, including Joseph Passalaqua, our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Disclosure controls and procedures include, without limitation, means controls and other procedures that are designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms and (ii) accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, because of the Company’s limited resources and lack of employees, management, including Joseph Passalaqua, our principal executive officer and principal financial officer, concluded that our disclosure controls and procedures were ineffective as of March 31, 2022 and as of the date of this filing, May 10, 2022.

 

Management has identified control deficiencies regarding inadequate accounting resources, the lack of segregation of duties and the need for a stronger internal control environment. Management of the Company believes that these material weaknesses are due to the small size of the Company’s accounting staff.  The small size of the Company’s accounting staff may prevent adequate controls in the future due to the cost/benefit of such remediation.  

 

To mitigate the current limited resources and limited employees, we rely heavily on direct management oversight of transactions, along with the use of external legal and accounting professionals. As we grow, we expect to increase our number of employees, which will enable us to implement adequate segregation of duties within the internal control framework.

 

These control deficiencies could result in a misstatement of account balances that would result in a reasonable possibility that a material misstatement to our financial statements may not be prevented or detected on a timely basis. In light of this material weakness, we performed additional analyses and procedures in order to conclude that our financial statements for the quarter ended March 31, 2022 included in this Quarterly Report on Form 10-Q were fairly stated in accordance with US GAAP. Accordingly, management believes that despite our material weaknesses, our financial statements for the quarter ended March 31, 2022 are fairly stated, in all material respects, in accordance with US GAAP.

 

Limitations on Effectiveness of Controls and Procedures

 

Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include, but are not limited to, the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

Changes in Internal Control over Financial Reporting

 

No changes in the Company's internal control over financial reporting have come to management's attention during the Company's last fiscal quarter that have materially affected, or are likely to materially affect, the Company's internal control over financial reporting.

 

19

 

 

 

 

PART II.  OTHER INFORMATION

 

ITEM 1.  LEGAL PROCEEDINGS.  

 

None.

 

ITEM 1A.    RISK FACTORS

 

As a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act), we are not required to provide the information called for by this Item 1A.

 

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

None.

 

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES.  

 

None.

 

ITEM 4.  MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5.  OTHER INFORMATION.

 

None.

20

 

 

 

ITEM 6.  EXHIBITS.

 

Exhibit Number		Description
31.1		Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1		Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
EX-101.INS		XBRL Instance Document*
EX-101.SCH		XBRL Taxonomy Extension Schema Document*
EX-101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document*
EX-101.DEF		XBRL Taxonomy Extension Definition Linkbase Document*
EX-101.LAB		XBRL Taxonomy Extension Labels Linkbase Document*
EX-101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document*

* The XBRL related information in Exhibit 101 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

 

 

21

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

	NINE ALLIANCE SCIENCE & TECHNOLOGY GROUP
Date:  May 10, 2022	By:	/s/ Joseph Passalaqua
		Name: Joseph Passalaqua
		Title: President Chief Executive Officer Chief Financial Officer

  

 

22